Limbus AI is a Canadian company based in Regina, Saskatchewan, founded in 2017. The company specializes in developing software for cancer radiation therapy, focusing on enhancing efficiency and clinical workflows through machine learning. Limbus AI aims to create innovative software solutions that integrate seamlessly with existing clinical systems, improving the accuracy and speed of treatment planning.

The company offers automatic contouring software for radiation therapy, utilizing deep learning segmentation to produce clinical-grade contours. Its flagship product, Limbus Contour, allows clinicians to develop precise treatment plans more quickly, addressing the increasing demand for radiotherapy services. Limbus AI’s technology has positively impacted around 500,000 patients across 400 centers worldwide, contributing to better patient outcomes in cancer care.

In May 2024, Limbus AI was acquired by Radformation, Inc., a leader in automation solutions for cancer care. This acquisition aims to enhance AI-driven innovations in radiation therapy by combining Limbus AI’s contouring technology with Radformation’s extensive global reach and product offerings.